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Quasispeciesmakes Autonomous Parvoviruses a valuable model for studies of virus–cell
interactions and gene therapy research. We developed a newMinute Virus of Mice variant, different from the
known prototype (MVMp) and immunosuppressive (MVMi) strains. The new virus variant, designated F1,
was isolated from the culture of semi-permissive Fisher Rat Fibroblasts, F111, infected with MVMp. The F1
genome carried point mutations in regions known to determine the mutually restricted host ranges of MVMp
and MVMi. In F111 cells, F1 cytotoxicity, gene expression and multiplication were signiﬁcantly higher
compared to MVMp. Conversely the wild-type virus propagated in MVMp-permissive cells more efﬁciently
than the F1. Reversion of the F1-speciﬁc mutations to wild-type MVMp sequence, following reverse-
passaging of the mutant virus in MVMp-permissive cells, conﬁrmed a speciﬁc adaptation of the F1 virus to
F111 cells. Considerable divergence in tissue speciﬁcities between the wild-type and mutant viruses was
demonstrated in vivo.
© 2008 Elsevier Inc. All rights reserved.IntroductionMinute Virus of Mice (MVM) belongs to the Autonomous
Parvoviruses (APVs), some of the smallest known animal viruses.
Their main common features are a single-stranded DNA genome of
about 5.1 kb with small terminal palindromes and icosahedral capsids
approximately 26 nm in diameter (Tattersall, 2006). Two APV
properties have drawn a lot of interest during the last three decades.
The dependence of APVs on both cellular proliferation factors,
expressed throughout S-phase, and the differentiation of host cells
to achieve lytic infection make them predominantly propagate in
rapidly dividing cells, sometimes achieving a remarkable oncotropism
(Cornelis et al., 2006). Although APV hosts are widely spread in the
animal kingdom, some parvovirus species are known to consist of
several strains, possessing different pathological spectra (Parrish and
Hueffer, 2006). Thus parvoviruses serve as a valuable model for the
study of virus–host interactions. In addition, the possibility of
constructing viruses with recombinant genomes (vectors), carrying
non-viral genes, makes APVs prominent objects for gene therapy
research (Cornelis and Dinsart, 2006).elit@zahav.net.il (R. Itah),
Keren-Naus),
.il (C. Davis).
l rights reserved.The MVM genome is replicated via double-stranded intermediates
and a rolling-hairpin mechanism (Cotmore and Tattersall, 2006). This
includes conversion of the single-stranded genome (ss, ∼5.1 kb) into a
double-stranded (ds) monomer replicative form (mRF, ∼5 kb),
subsequent synthesis of a dimer form — dRF (dsDNA ∼10 kb), con-
taining two copies of the original genome, as well as additional
intermediates. Finally, this is followed by resolution and packaging of
ss genomes. Both viral nonstructural proteins (NS) and cellular factors,
expressed in the S-phase, are necessary for the process.
The MVM genes are organized into two overlapping transcription
units with promoters located at map units (m.u.) 4 (P4) and 38 (P38)
(Pintel et al., 1983) transcribing three main mRNAs. P4 controls
synthesis of R1 (4.8 kb) and R2 (3.3 kb), while P38 regulates R3 (3 kb)
production. R1 and R2 are produced from the same pre-mRNA, but
R2 lacks the large intron between m.u. 10 and 39. All three mRNAs
undergo splicing of the small intron between m.u. 46 and 48 (Qiu
et al., 2006). NS1 (83 kDa) and NS2 (24 kDa) are translated from R1
and R2 respectively (Cotmore and Tattersall, 1986). Both of these are
necessary for virus replication and cytotoxicity (Nuesch, 2006). All
capsid proteins are synthesized from R3 transcripts. VP1 (83 kDa)
and VP2 (64 kDa) are produced by alternative splicing, while VP3
(comprising about 90% of virus full capsids) is generated by
posttranslational cleavage following DNA packaging (Tattersall
et al., 1977).
The P4 and P38 promoters possess similar basic promoter ele-
ments: SP1 binding sites, TATA boxes, and putative initiator sequences
(Lorson and Pintel, 1997). P4 contains several additional regulatory
sequences, and may be expressed in the absence of viral proteins
Table 1
Mutations found in the F1 mutant virus
Nucleotide
position (bp)
Nucleotide
change
VP change
(amino acid)
VP1 amino
acid position
VP2 amino
acid position
1955 G to A – – –
3793 G to A Ala to Thr 476 334
3944 A to C Glu to Ala 526 384
4453 A to G Asn to Asp 696 554
4525 A to C Ile to Leu 720 578
PCR ampliﬁcation products of the packaged virus DNA were sequenced (Materials and
methods). Positions of nucleotide changes are indicated according to the GenBank
MVMp sequence (accession number J02275). Amino acid changes are indicated relative
to GenBank MVMp sequences (NP_041244.1 and NP_041248.1 for VP1 and VP2,
respectively).
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expression, but can be upregulated (∼100 fold) by NS1, which acts as a
transcriptional activator (Doerig et al., 1988), binding to a speciﬁc DNA
regulatory sequence at the promoter (Cotmore et al., 1995).
MVM serves as a goodmodel of parvoviral strain-speciﬁc variation.
The prototype (MVMp) and immunosuppressive (MVMi) strains
efﬁciently propagate in culturedmouse ﬁbroblasts and T lymphocytes,
respectively. Their host ranges are reciprocally restricted, although
they are serologically indistinguishable and exhibit only ∼3% DNA
sequence divergence (Tattersall and Bratton, 1983). Signiﬁcant
differences in the tissue tropisms of these two MVM strains were
also found in newborn mice (Kimsey et al., 1986) and mouse embryos
(Itah et al., 2004b).
The mechanism restricting infection of MVMp and MVMi in each
other's host cells is not fully understood, but is considered to be
intracellular, rather than occurring on the outer cell membrane
(Spalholz and Tattersall, 1983; Previsani et al., 1997). There are at least
two kinds of host range determinants, one located in capsid coding
region and the other in the large-intron 3′ splice site, that are
responsible for MVM ﬁbrotropism. Recombinant MVMi carrying two
amino acids speciﬁc to MVMp in the capsid coding region (at the VP2
positions 317 and 321) was shown to infect ﬁbroblasts more than 100
times better than the original MVMi (Gardiner and Tattersall, 1988).
Either of these substitutions, complemented with additional changes
(deﬁned as second-site mutations), was shown to confer ﬁbrotropism
on MVMi. Structurally, the 317 and 321 VP2 amino acids, as well the
second-site mutations are associated with a dimple-like depression
located at the icosahedral two-fold axis in the MVM capsid. This site
was proposed to be involved in the interaction of the viral particles
with sialic acid, crucial for infection (Agbandje-McKenna et al., 1998;
López-Bueno et al., 2006a). The second host determinant establishes
the ability of the virus genome to express NS2. A silent guanine to
adenine substitution in MVMi at nt 1970 was demonstrated to cause a
dramatic increase in NS2 levels via increased large-intron splicing in
mouse ﬁbroblasts. This correlated with elevated virus ssDNA (Choi
et al., 2005). The same mutation and a similar substitution at nt 1967
were found in MVMi mutants with plaque forming capability in
ﬁbroblast monolayers (D'Abramo et al., 2005).
It is not knownwhat the adaptive cell-type range of MVM or other
autonomous parvoviruses is. It has been shown that forced culture
(persistent infection) of MVMi in mouse ﬁbroblasts can lead to an
acquired ﬁbrotropism (Ron et al., 1984). The objective of this work was
to further characterize the adaptive range of MVM through persistent
infection of non-murine cells that are restrictive to the wild-type
virus. Prolonged MVMp infection of F111 Fisher Rat Fibroblasts
resulted in the preferential selection of a mutant virus, called F1.
This mutant was shown to be speciﬁcally adapted to propagation in
F111 cells in vitro, and its in vivo host range diverged considerably
from that of wild-type MVMp. We describe here the derivation of F1,
its infection in F111 and normal MVM hosts compared to the parental
MVMp. Sequencing and expression studies showed the effect of the
observed genome alterations on the infection parameters in tissue
culture and in vivo. Structural mapping localized the coat protein
residues mutated in the F1 virus to the sialic acid binding region at the
icosahedral two-fold axis of the MVM capsid.
Results
Adaptation of MVMp to rat ﬁsher embryonic ﬁbroblasts (F111 cells)
We tested the ability of MVMp to extend its tropism to a non-
murine, semi-permissive host cell-type, F111 rat ﬁbroblasts. These
cells were infected with 2 PFU/cell of transfection-derived MVMp
(Materials andmethods). A moderate cytopathic effect (CPE) appeared
3 days post infection (dpi), followed by quick culture recovery (4–
5 dpi) and subsequent normal cell growth. However, despite normalcell growth, cell cultures at 14 dpi contained virus— as determined by
plaque assays in A9 cells. Infection of naive F111 cells with 14 dpi virus
led, once again, to mild cell death followed by full recovery of the
culture. DNA sequencing of F111-extracted viral samples revealed no
differences from the wild-type (WT) MVMp genome.
We hypothesized that increased divergence of the initial viral
population could increase chances of successful selection of adaptive
changes. We reasoned that multiple cycles of infection in a permissive
host should create the high genetic heterogeneity that has been
reported for the parvoviruses (López-Bueno et al., 2006b). We
therefore cultured transfection-derived MVMp virus through 5
successive passages in permissive A9 cells (Materials and methods).
F111 cells infected with this A9-passaged virus (MVMp-A9) exhibited
no differences in CPE compared to infection with the transfection-
derived MVMp. However, virus extracted following 14 days of
prolonged MVMp-A9 infection in F111 cells (designated as MVMp-
F111) was capable of effectively destroying naive F111 cell cultures,
unlike transfection-derived MVMp or MVMp-A9 (Supplementary
material, Fig. 8).
Puriﬁcation and sequencing of F111-adapted virus
Sequencing of MVMp-F111 led to ambiguous results, presumably
because of genomic heterogeneity. Therefore virus was puriﬁed both
by end-point dilution in F111 cells and plaque puriﬁcation in A9 cells.
14 of 20 plaque-puriﬁed samples and all end-point dilution isolates
destroyed F111 cultures upon infection. The plaque puriﬁcation results
likely reﬂected genomic heterogeneity of the MVMp-F111 population,
whereas only subpopulation/s with the ability to destroy F111 culture
could be isolated by end-point dilution in these cells.
Viral DNA from 5 plaque-puriﬁed samples, with the ability to kill
F111 cells, and 5 end-point dilution isolates were sequenced and a
single mutational pattern, designated F1, was revealed (Table 1). 4 of 5
identiﬁed mutations occurred on the capsid protein coding sequence,
leading to amino acid changes. One mutation, G1955A, was located
within the NS1 coding sequence, near the large splice branch-point,
and within the consensus SP1 binding site of the P38 promoter. With
respect to translation, the substitution is silent (Fig. 1A).
Locations of F1 mutations on the 3D structure of MVMp capsid (VP2)
As shown in Fig. 1B, the four mutations in F1 that resulted in amino
acid changes in VP regions of the coat protein (Table 1) were mapped
onto the MVMp structure determined by X-ray crystallography
(Kontou et al., 2005), in order to evaluate the structural impact of
the changes at a tertiary and quaternary protein structure level.
Residue A334, buried inside the capsid, has a side-chain that points
into a hydrophobic pocket and is involved in the stabilization of three-
fold inter-subunit interactions. The three remaining amino acid
residues, E384, N554 and I578, are located on the capsid surface,
clustering around the depressions at the icosahedral two-fold axis of
Fig. 2. Wild-type G1955 and mutant 1955A promoter activity. 105 F111, A9, NB324K, or
PyF cells were co-transfected with the indicated CATconstruct, pNS and pSV2βgal (as an
internal control of transfection). Relative CAT activities are represented as percentages
of the normalized CAT activity achieved by pP38[WT]-CAT in A9 cells. Error bars show
the standard deviation for 3 independent replicates.
Fig. 1. Representation of alternations found in the F1 mutant. (A) P38 promoter region.
The DNA sequence and its corresponding NS1 amino acid sequence are represented
according to GenBank sequences J02275 and NP_041242, respectively. Locations of the
G1955A substitution, found in F1, of A1970, the branch point for excision of the large
intron from NS-coding pre-mRNA in A9 cells (Choi et al., 2005), and of core promoter
elements are indicated. (B) Mutated VP residues, found in F1 (Table 1) were mapped
onto the X-ray crystal structure model of the MVMp capsid (residues 39–587). The top
panel shows a stick representation of the 4 residues (in green) in the context of the
backbone trace of the VP2 polypeptides shown in the different colors for icosahedral
symmetry related monomers (yellow), cyan (two-fold), orange and magenta (three-
fold), and bluish purple (ﬁve-fold). The bottom panel shows the same view with a
surface representation. The sialic acid mapped onto the MVMp capsid surface (López-
Bueno et al., 2006a,b) is shown in both panels in the right-hand-side two-fold pocket,
with the carbons in cyan, the oxygens in red and the nitrogens in blue. The two-fold axis
is shown with the ﬁlled oval.
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receptor binding site in MVMp (Fig. 1B). E384 is located in a surface
loop at the shoulder of the protrusions at the icosahedral three-fold
axes and is involved in interactions with S388 and P392 that are likely
required for stabilizing the conformation of their loop. Residue S388 is
an MVMp/MVMi differing residue that has not yet been implicated in
their tissue tropism differences. N554 and I578 are located on the wall
and ﬂoor, respectively, of the two-fold dimple depression on the
capsid surface, also within the vicinity of the sialic acid receptor
binding site (Fig. 1B) (López-Bueno et al., 2006a).
CAT reporter gene assay of the mutant P38 promoter
We hypothesized that the silent substitution, G1955A, (Fig. 1A)
would affect viral gene expression, as it lies within the consensus SP1binding site of the P38 promoter. To test this we transfected mutant
andWT CAT reporters into different host cells. Two promoter/reporter
constructs containing the CAT sequence under control of a WT (pP38-
[WT]) or mutant (pP38-[1955]) P38 promoter were made. An
additional plasmid, pNS, expressing the viral NS1 protein, which
activates P38 expression (Doerig et al., 1988), was also constructed
(Materials andmethods). pNS and the P38-reporter plasmids were co-
transfected into different host cells and CAT activity measured after
48 h (Fig. 2). The results showed that the 1955 substitution caused a
marginal, but sometimes signiﬁcant, reduction in P38 activity in all
checked cell-types, including F111 cells (Fig. 2). The data suggest that
this mutation likely contributes to F1 adaptation by some other way
than altering its P38 expression in F111 rat ﬁbroblasts, such as an
elevated accumulation of NS2.
Virus quasispecies during culture and host cell-type shifts
To identify and follow the relative frequencies of the characterized
sequence variants during propagation in different cell cultures, we
adapted an ARMS allele-speciﬁc PCR technique (Newton et al., 1989).
For each variant location, selective and unselective ARMS primers
were designed (Table 3) and used for allele-speciﬁc PCR. It was
possible to speciﬁcally amplify WT or mutant plasmid DNA templates
in quantities ranging from 0.1 fg (∼20 plasmid molecules) to 10 ng
(∼2⁎109 molecules) and effectively identify alleles in mixed WT and
mutant DNA pools in ratios of 1:108, for each of the variant loci (Fig.
3A). Although the assay is not strictly quantitative we consistently
obtained easily identiﬁable distinctions among quantities of PCR
products when signiﬁcantly different template amounts were used for
reactions, indicating that the ARMS could reliably assay divergence in
quasispecies content for each variation identiﬁed in our viral samples.
The calibrated allele-speciﬁc ARMS PCR was used to characterize
the sequence variants present in populations of viruses isolated from
our culture experiments. The initial selection experiments indicated
that F1mutant virus arose only fromMVMp that had been passaged in
A9 cells (MVMp-A9), not from virus produced directly following
transfection of the infectious cloned MVMp (MVMp-pMM984)
(Materials and methods). We hypothesized that MVMp adaptation
to the F111 cells occurred through selection of quasispecies present in
the MVMp-A9 population. We therefore characterized the frequency
of the sequence variants in the different viral stocks by ARMS. The data
show that the variants selected during F111 cell culture were present
in MVMp-A9, but not in MVMp-pMM984 (Fig. 3B). Although MVMp-
F111 virus consisted of mixed WT and mutant subpopulations, only
mutant loci were detected in its end-point dilution isolate (F1-EPD).
Subsequent propagation of this isolate in F111 cells to obtain sufﬁcient
Fig. 3. ARMS calibration and analysis of virus samples. In each allele-speciﬁc PCR (35 cycles), a selective primer for either wild-type (WT) or mutant (M) template, along with
the conventional unselective primer (Table 3), was used. Results of tests for 1955 and 4453 bp positions are shown. Reaction products and 100 bp DNA Ladder (New England
BioLabs) were resolved by 1.5% agarose gel electrophoresis. (A) ARMS speciﬁcity test. Plasmids with cloned wild-type MVMp DNA (pP38-WT, pVP-WT), plasmids carrying F1
mutant pattern (pP38-1955, pVP-F1), or plasmid mixtures in the indicated quantities were tested with ARMS. (B) Presence of the wild-type and mutant DNA in viral samples.
The indicated viral samples (see text) were checked with ARMS. (C) Sequence selection during serial passage of mutant virus in different host cell-types. F1 mutant virus was
serially passaged 5 times (1P–5P) in the indicated cell lines. At each passage, 4⁎105 cells were infected with 0.2 PFU/cell. After cell culture death, virus was extracted and ARMS
performed.
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reversion of the F1 mutations to WT (Fig. 3B).
If the F1 mutations that became predominant following culture in
F111 rat ﬁbroblasts were an adaptive response to a poorly permissive
host, we reasoned that these changes would be preserved during F1
propagation in these cells, but that repeated infections of known
MVMp hosts cells with F1 would result in reversion — the appearance
and enrichment of a WT MVMp subpopulation. To check this hypo-
thesis we passaged F1 in A9, NB324K, PyF and F111 cells 5 times. 2–3
passages (4–6 cycles of infection) of virus in all of these host cell-typesled to the appearance of quasispecies, with reversion toward the WT
MVMp pattern (Fig. 3C). These subpopulations were continuously
enriched during subsequent passages in A9 and NB324K cells, and
clearly dominated the viral populations after the 5th passage (∼10
infection cycles). Passaging of F1 in PyF cells also resulted in the
appearance of WT sequence. However, after 5 passages, (Fig. 3C)
subpopulation/s carrying F1 mutations still composed a signiﬁcant
fraction of the viral sample and after further 5 passages F1-speciﬁc
sequence was still clearly present (data not shown). Although
quasispecies with WT sequence appeared also during the F1
Fig. 4. Cell culture conﬂuency following MVMp and F1 infection. 2000 A9 or NB324K cells in 96 well microtiter plates were infected with 2 PFU/cell (High MOI) or 0.2 PFU/cell (Low
MOI) of MVMp or F1. Conﬂuency of surviving cells was measured spectrophotometrically by MTT assay (Materials and methods). Bars represent the standard deviations in 10
independent trials.
249I. Etingov et al. / Virology 379 (2008) 245–255propagation in F111 cells, their level was low and F1 remained
dominant (Fig. 3C). Although allele compositions are illustrated for the
variant loci at nt 1955 and 4453, similar results were obtained for the
other alleles at nt 3793, 3944 and 4525 (data not shown).
Infection characteristics of F1 in comparison with wild-type MVMp
To examine the effects of the suite of selected mutations on in-
fectivity, we characterized the responses of different host cells to
infection by parental and variant viruses. A cell survival test (Fig. 4)
showed that F1-killing of A9, NB324K and PyF cells was undistin-
guishable from WT MVMp at high MOI (2 PFU/cell). However,
infections with low MOI (0.2 PFU/cell) demonstrated a signiﬁcant
delay in the destruction of these cultures by F1 compared with WT
MVMp (Fig. 4). F1 also exhibited signiﬁcantly lower infectious viral
particle production in MVMp-permissive cells compared to WT virus
(Table 2). A diminished ability of F1 to propagate in A9 and NB324K
cells was veriﬁed by comparing the plaque morphology of theWT and
mutant viruses on monolayers of these cells. Plaques formed by F1
were signiﬁcantly smaller than those formed by MVMp (Supplemen-
tary material, Fig. 9). Infections of F111 cells conﬁrmed that only F1
was capable of destroying these cells (Fig. 4), and that F1 propagates inTable 2
Active viral particle production by different cell lines (PFU/cell)
Virus Cells
A9 NB324K PyF F111
MVMp 1120 (±43) 1051 670 (±19) 0.4 (±0.02)
F1 88 (±4.2) 69 (±2) 310 (±9.1) 21 (±0.7)
106 cells of each type were infected by WT MVMp or the F1 mutant with a MOI 2 PFU/
cell. 3 dpi virus was extracted and plaque assays were performed in A9 cells (Materials
and methods). Numbers in brackets are standard deviations calculated from 5
independent infections.these rat ﬁbroblasts signiﬁcantly more efﬁciently than WT MVMp
(Table 2).
Host-dependent differences in viral products during MVMp and
F1 infection
To better understand the effects of the naturally selected variations
on the viral lifecycle we compared some of the major parameters of
MVM infection by F1 and theWT virus. Both virus strains were used to
infect rat F111 and PyF cells, as well as the typical WTMVMp hosts, A9
and NB324K cells. Low molecular weight DNA was extracted at 1 and
24 h following infection andMVM genomic DNA detected by Southern
blot (Fig. 5). As might be expected from selection and cytotoxicity
results in F111 rat ﬁbroblasts, the level of F1 DNA replication forms
(RF) in these cells was signiﬁcantly higher than that of wild-type
MVMp. Vice versa, the infection of MVMp-permissive cells A9 and
NB324K showed preferential WT virus replication (Fig. 5, 24 hpi
assays). Cell extracts prepared 1 h after infection contained similar
quantities of the virus genomic single-stranded (ss) DNA (Fig. 5, 1 hpi
assays). The source of ssDNA at this early stage of infection, in the
absence of any detectable RF could be only MVM packaged genomic
DNA, i.e. the inoculum, indicating that there is no signiﬁcant
difference between the binding abilities of WT and mutant viruses
to the surfaces of any of the checked cell-types. The similar levels of
ssDNA 1 h after infection and the considerable differences in
replication levels 24 hpi suggest that the infections of WT MVMp in
F111 and the F1 variant in A9 and NB324K cells are reciprocally
impaired at some stage between capsid attachment to a cell and virus
DNA replication. Finally it was likely that this difference is transfor-
mation-dependent; WT MVMp replication was moderately higher in
PyF cells than the replication of F1.
We characterized the products ofMVMp and F1 gene expression by
Northern and Western analyses at 14 and 24 h post-infection
respectively (Fig. 6). Higher levels of F1 genome expression products
Fig. 5. Wild-type MVMp and F1 mutant DNA replication. F111, A9, NB324K, or PyF cell cultures were infected with 2 PFU/cell of either wild-type MVMp or mutant F1 virus. Low
molecular weight DNAwas extracted one and 24 h after infection (hpi). Extracted DNA from 104 cells and a Lambda-HindIII DNA size marker (NEB) were resolved by 0.8% agarose gel
electrophoresis and subjected to Southern blot analysis usingmixedMVMp and Lambda labeled DNA as a probe. dRF— dimer replicative form, mRF—monomer replicative form, ss—
single-stranded genome.
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signiﬁcantly increased amounts of MVMp mRNA and proteins were
expressed in A9 and NB324K cells. MVMp was found to have only
slightly increased expression from either of its promoters compared to
F1 in PyF cells (Fig. 6). WT MVMp expression of R2 mRNA and NS2
protein (synthesized fromR2) appeared to be particularlyweakened in
F111 rat ﬁbroblasts, even as F1 infection produced signiﬁcantly higher
quantities of R2 and NS2 in these cells (Figs. 6A and B, respectively).
Differences between the in vivo host ranges of MVMp and F1
Because of the limited infection of Minute Virus of Mice in normal
adult mice, we used an in utero injection technique (Itah et al., 2004a)
to characterize differences in the host cell-type range in vivo. Viral
inoculation of mouse embryos at 12 dpc revealed infection of boneFig. 6. Wild-type MVMp and F1 mutant genome expression. (A) Transcription assay.
F111, A9, NB324K, or PyF cell cultures were infected with 2 PFU/cell of either wild-type
MVMp ormutant F1 virus. mRNAwas extracted 14 h later. 100 ng of mRNAwas resolved
by formaldehyde agarose (1%) gel electrophoresis. A Northern analysis was per-
formed using wt MVMp labeled genomic DNA as a probe. R1 — NS1-encoding P4 tran-
script, R2 — spliced, NS2-encoding P4 transcript, R3 — structural protein P38 transcript.
(B) NS protein expression. The indicated cell cultures were infected with 2 PFU/cell of
either wild-type MVMp or mutant F1 virus. 24 hpi total protein was extracted and
spectrophotometrically quantiﬁed. Samples of 10 μg of total protein were resolved by
discontinuous SDS-Polyacrylamide gel (10%) electrophoresis. NS1 and NS2 proteins
were detected by Western analysis using anti-NS polyclonal antisera and a peroxidase-
labeled anti-rabbit secondary Ab. (C) Capsid protein expression. Total protein was
produced as for NS. Samples of 10 μg of total protein were resolved by discontinuous
SDS-Polyacrylamide gel (8%) electrophoresis. VP1 and VP2 proteins were detected by
Western analysis using anti-VP polyclonal antisera and peroxidase-labeled anti-rabbit
secondary Ab.primordia by F1, that unlike the parental MVMp was accompanied by
signiﬁcant tissue destruction (Fig. 7A). In contrast, F1 exhibited
reduced infection of skin ﬁbroblasts (Fig. 7B) and no apparent
infection in either CNS or PNS (data not shown), tissues that both
exhibited sporadic infection with MVMp (Itah et al., 2004b).
A preliminary study of MVMp and F1 infection, using the neonate
oronasal inoculation model (Kimsey et al., 1986) also indicated some
divergence between MVMp and F1 infection patterns (Supplementary
material, Fig. 10).
Discussion
Extension of MVM tropism as a result of quasispecies enrichment
Minute Virus of Mice has been shown to readily adapt to new host
environments both in cell culture (Ron et al., 1984) and in vivo (López-
Bueno et al., 2003). Darwinian selection apparently leads to a shift in
predominant virus variants inMVMpopulations as a result of environ-
mental constraints such as a new host or treatment with antibodies
against MVM capsid. We show here that the same principle could be
exploited to adaptMVM to non-murine, poorly permissive cells. F111, a
rat ﬁbroblast cell-line, is restrictive (semi-permissive) for MVMp
(Guetta et al., 1990). The prolonged infection of F111withMVMp led to
the predominance of an adapted variant, designated as F1. In contrast
to the parental MVMp, F1 destroyed F111 ﬁbroblast cultures.
The analysis was informative with respect to the mechanics and
speed of the adaptive process. F1 arose in F111 cells infected with
MVMp only if the inoculating MVMp was derived from successive
infection cycles in a permissive host. F1 did not arise in F111 cells
infected with standard transfection-derived MVMp (Materials and
methods). We suggested that the successful enrichment and eventual
domination of the F1 mutant was due to the presence of quasispecies
in the initial virus sample used for the infection of F111 cells. This was
conﬁrmed by allele-speciﬁc PCR (ARMS), that demonstrated the
presence of all F1-speciﬁc nucleotide substitutions in A9 passaged
MVMp, but not in transfection-derived virus samples.
Finally, F1 adaptation to the F111 cells was a coevolutionary
process. Persistently infected rat ﬁbroblasts sustained a normal rate of
cell growth, without any signs of CPE, for the entire period of the
persistent infection (we maintained the infected culture growth up to
2 months), with continuous production of the mutant virus, revealing
the resistance of the culture to this mutant. In contrast, virus extracted
from such cultures destroyed naive F111 cells.
The F1 mutant genome
The locations of the F1 mutations in the MVM genome indicate
that adaptive determinants for F1 in rat ﬁbroblast F111 cells are in
Fig. 7.Histological distribution ofMVMp and F1 infections inmice embryonic tissues. Embryoswere injected through uterinewall and further processed as described inMaterials and
methods. The sample data is represented in pairs of DIC images (left panels) and Fluorescence images, showing distribution of viral capsids (right panels). Typical transverse sections
through primordial bone (A) and skin (B) tissues are represented.
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ciprocal tropism of the ﬁbrotropic (MVMp) and lymphotropic
(MVMi) strains of MVM, and adjacent to residues identiﬁed in
virulent MVMp mutants isolated from SCID mice (López-Bueno
et al., 2006a). Two of four VP F1-speciﬁc mutations (334 and 384
VP2 amino acid positions) are located within the MVM ﬁbrotropic
determinant region (Gardiner and Tattersall, 1988), with the E384
side-chain performing a stabilizing role for a surface loop through
its interactions with the main-chain of MVMi/p differing residue
S388 contained within this loop. Mutations of residues in a
homologous loop to this one in canine parvovirus at amino acid
positions K387A and T389 to alanine in CPV have been reported to
result in a non-infectious CPV phenotype (Parker and Parrish, 1997).
The remaining two residues, N554 and I578 are structurally
clustered adjacent to other MVMi/p differing residues, VP2 residue
mutations (399, 460, 553, 558) known to be involved in adaptation
of MVMi to A9 ﬁbroblasts and MVMp amino acids (362, 368, 551,
575) that mutate in SCID mice to confer a virulent phenotype to
this otherwise non-pathogenic virus (Agbandje-McKenna et al.,
1998, Kontou et al., 2005, López-Bueno et al., 2006a). These ob-servations suggest that local capsid surface topology changes, re-
sulting from these mutations of the MVMp residues to those ob-
served in F1, facilitate host range adaptation. The location of all the
F1 capsid mutations at or close to the capsid surface pocket where
MVM is predicted to binds its sialic acid receptor further supports
the possibility of extension of MVM host range by adaptation of its
structural tissue tropism and pathogenicity determinants to a new
host.
Despite the location of the F1 residues close to the MVM
receptor binding site, binding afﬁnity does not appear to be altered
in the mutant virus as determined by the similar levels of genomic
DNA isolated from infected cells 1 h post infection (Fig. 5). This
observation supports a restrictive block post entry that involves a
capsid-mediate interaction/dynamic that is not yet identiﬁed as is
the difference between WT MVMp and MVMi. This phenotype
differs from that observed for MVMp adaptation to a virulence
phenotype, which resulted in decreased afﬁnity for the cell surface
sialic acid, and an increased viral spread consistent with a large
plaque phenotype compared to the WT MVMp (López-Bueno et al.,
2006a; Nam et al., 2006). Signiﬁcantly, the localization of the VP2
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axis is consistent with other tissue tropism and pathogenicity
determinants for parvoviruses in general (reviewed in Kontou et al.,
2005), and further implicates the parvoviral two-fold region in this
phenomenon.
The silent G1955A substitution is found in the region known to
regulate large-intron splicing (Pintel et al., 1995). Substitutions within
this region have been shown to affect large-intron splicing in a cell-
dependent manner. MVMi carrying one of the silent G1967A or
G1970A was demonstrated to increase NS2 levels in A9 ﬁbroblasts
(D'Abramo et al., 2005). The interaction between adenosine at the
splicing branch point and theU2 snRNA is crucial for splicing (Moore et
al., 1993). The G1970A substitution in MVMi was demonstrated to
signiﬁcantly improve large-intron splicing and increase both R2 and
NS2 levels in A9 ﬁbroblasts by modifying the interaction with
endogenous U2 snRNA (Choi et al., 2005). It is therefore similarly
possible that the substituted adenosine at nt 1955 alters binding of U2
snRNA to the large-intron splicing branch point in F111 rat ﬁbroblasts.
The signiﬁcantly enhanced production of R2 and NS2 by F1 in F111
supports this hypothesis. NS2 is known to be involved in several MVM
functions such as virus DNA replication (Naeger et al., 1990), mRNA
translation (Naeger et al., 1993), nuclear egress of progeny virions in
mouse cells (Eichwald et al., 2002) and particle assembly (Cotmore
et al., 1997).
Current study does not reveal what mutation/s or their combina-
tion can be sufﬁcient for the virus–host range switch from mouse to
rat ﬁbroblasts. Lymphotropic MVMi was demonstrated to require at
least two capsid amino acid alternations associated with sialic acid
binding region in order to adapt to A9 ﬁbroblasts (Ball-Goodrich and
Tattersall, 1992; Agbandje-McKenna et al., 1998). Alternatively
ﬁbrotropism can be conferred to MVMi by combination of one of
the silent substitutions facilitating NS2 production (G1967A or
G1970A) and one of the additional VP2 amino acid changes at the
position 399 (D399G or D399A) (D'Abramo et al., 2005). Thus we think
that the extension of our study possibly can reveal very limited
number of genomic changes in MVM genome, conferring trans-
species host range change to the virus.
Speciﬁcity of the F1 host range
Several lines of evidence indicate considerable differences
between host-range properties of the WT MVMp and the F1 mutant.
In vitro, F1 infection at even a low multiplicity (0.2 PFU/cell) efﬁ-
ciently destroyed F111 rat ﬁbroblasts culture, whereas infection of
these cells with a high multiplicity of WT MVMp (2 PFU/cell) caused
only a slight CPE, followed by full recovery of the culture. DNA
replication and genome expression of F1 were signiﬁcantly better in
F111 cells, while the WTMVMp had a substantial advantage in A9 and
NB324K. Although the mutant viruses were selected in a rat tissue
culture host, we showed that F1 was able to infect mouse embryos in
utero and that there was signiﬁcant divergence between the WT
MVMp and F1 mutants in their infection properties. Finally F1-
speciﬁc mutations were preserved only during propagation in F111
cells; passaging in A9 and NB324K cultures resulted in reversion to
the WT MVMp pattern. Interestingly, even PyF cells, which are
transformed F111 cells and therefore of rat origin, were more
supportive of WT MVMp than F1 infection, indicating the high spe-
ciﬁcity of the cellular factors determining parvovirus tropism and
highlighting the effect of transformation on the biology of the
autonomous parvoviruses.
We suggest that further studies in this direction could lead to
generation of autonomous parvoviruses with desired host range
properties, permitting construction of gene therapy vectors with
determined targeting and a better understanding of the role of cell
transformation in determining the characteristics of parvovirus-host
cell biology.Materials and methods
Cell culture
A9 mouse ﬁbroblast cells (Littleﬁeld, 1964), NB324K simian virus
40-transformed human newborn kidney cells (Shein and Enders,
1962), F111 Fisher rat ﬁbroblasts (Freeman et al., 1973), and PyF
polyomavirus-transformed F111 cells (Guetta et al., 1990) were
cultured in monolayers in Dulbecco modiﬁed Eagle medium (Gibco
Laboratories) supplemented with 5% inactivated fetal bovine serum at
37 °C, 5% CO2.
Virus
MVMp was produced by transfection (see below) of its infectious
clone pMM984 (Merchlinsky et al., 1983) into A9 cells. After cell death,
virus was extracted by standard procedure (Tattersall et al., 1976) and
was not further passaged.
F1 mutant virus was produced by end point dilution of the
MVMp-F111 isolate (see “Results”) in F111 cells followed by sub-
sequent propagation in these cells. Typically 106 cells in a 150 mm
plate were infected with 10−2 PFU/cell and ∼107 PFU/plate was
obtained. Resulting virus was checked by direct PCR and sequencing as
well as by sequencing of its Plaque Puriﬁed isolates. In addition, F1
stocks were routinely checked by ARMS (see below). All controls did
not reveal genomic heterogeneity.
Transfections and Infections
All transfections/co-transfections were done with FuGENE 6
transfection reagent according to themanufacturer's (Roche) protocol.
For MVMp infections, the desired host cells were seeded and 12 h later
the growth medium was replaced by Dulbecco modiﬁed Eagle
medium without serum (1/10 of a normal volume), containing active
viral particles at the desired multiplicity of infection (MOI). After 1 h
incubation with gentle shaking under the standard cell growth
conditions (see above), the inoculumwas removed, cells were washed
with PBS and grown under the standard conditions (see above). For
virus passage experiments, 106 cells were infected with 0.2 PFU/cell
and cultured until cell death. Virus extracted was subsequently used
for a further infection of the same cell-type with the same MOI.
Plaque assays/puriﬁcation
Standard procedure (Tattersall and Bratton, 1983) was used to
determine the amount of active virus particles (PFU) in our viral
samples. Plaque puriﬁcation was performed as described elsewhere
(Tattersall, 1972). End point dilutions of mutant viruses in F111 cells
were performed in 96 well plates according to general protocol (Mahy
and Kangro, 1996).
PCR assays
Viral templates for PCR were treated with 20 μg/ml DNAse (NEB)
for 1 h to remove contaminating genomic and viral Replicative Form
DNAs.
To amplify the coding sequences of the MVM genome by a single
reaction, the F117 (ATAAGCGGTTCAGGGAGTTTA) and R4928
(CTGAATAGACAGTAGTCTTGGTTGAG) primers were used in the
Expand Long Template PCR System (Roche). A prolonged initial
denaturation of 95 °C for 10 min was introduced to destroy viral
capsids. 35 thermal cycles consisting of denaturation at 95 °C for
45 s, annealing at 55 °C for 30 s, elongation at 72 °C for 5 min
followed by a ﬁnal elongation at 72 °C for 15 min were performed.
Ampliﬁcation-Refractory Mutation System (ARMS) allele-speciﬁc
PCR (Newton et al., 1989) included one constant unselective primer
Table 3
Primer sets used for ARMS
Genome position
(bp)
SNP Allele-speciﬁc primers
(name and sequence)
Unselective primer
(name and sequence)
Reaction annealing
temp. (°C)
Product size
(bp)
1955 G — WT R1974-WT; 5′gagttggcacctttggctac F1629; 5′gccatttgctctggtcaaactat 61 345
A — mutant R1974-M; 5′gagttggcacctttggctat
3793 G — WT R3814-WT; 5′gttgacaaaatcctacttgatc F3449; 5′gagatctttcagtgacctacg 54 365
A — mutant R3814-M; 5′gttgacaaaatcctacttgatt
3944 A — WT R3961-WT; 5′catgtgaagcccaattat F3449; 5′gagatctttcagtgacctacg 53 512
C — mutant R3961-M; 5′catgtgaagcccaattag
4453 A — WT R4473-WT; 5′actcatgtatgagttgccagt F4092; 5′ccctattgggactaaaaatgac 58 381
G — mutant R4473-M; 5′actcatgtatgagttgccagc
4525 A — WT R4544-WT; 5′ctagcaacaggtcttgttgt F4092; 5′ccctattgggactaaaaatgac 56 452
C — mutant R4544-M; 5′ctagcaacaggtcttgttgg
Single nucleotide polymorphisms (SNP) at the indicatedmutant loci were checked for each one of the depicted genome positions by two allele-speciﬁc PCRs. Each reaction employed
one of the shown selective allele-speciﬁc primers, (one designed to speciﬁcally amplify the wild-type [WT] and another the mutant [M] templates), along with the corresponding
unselective primer.
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of 95 °C for 10 min was used to destroy the viral capsids. Ampliﬁ-
cation consisted of 35 cycles of denaturation at 95 °C for 30 s,
annealing for 30 s at a temperatures speciﬁc for each reaction (Table
3), and elongation at 72 °C for 30 s. A ﬁnal elongation at 72 °C for 2min
was included. All reactions were performed in 50 μl volumes. Each
reaction contained: 1 U of Taq polymerase (Super-Nova), 5 μl of 10X
Taq buffer supplemented with 15 mM MgCl2 (Super-Nova), 100 μM
each of dNTPs, 0.1 μM each of a selective and an unselective primer.
Reaction products and a 100 bp DNA Ladder (NEB) were resolved by
agarose gel (1.5%) electrophoresis (5 V/cm) and identiﬁed by staining
with EtBr.
Four test templates for the ARMS allele-speciﬁc PCR assay were
constructed. pVP-WT and pVP-F1 were made by PCR ampliﬁca-
tion of the region 3449-4867 in WT MVMp and F1 DNA res-
pectively, using the primers F3449 (see Table 3) and R4867-EcoRI
(CATCAAGTCTAAGGGAATTCC), which introduced an EcoRI endo-
nuclease restriction site into the PCR product. The EcoRI-cut pro-
duct was then cloned into the EcoRI site of the plasmid pGEM
(Promega). To produce pP38-WT/pP38-1955, MVMp/F1 PCR-ampli-
ﬁed DNA sequences, between two EcoRI sites (located at positions
1084 and 3522 of theMVM genome) were cloned into the EcoRI site of
pGEM.
Sequencing
PCR products were puriﬁed by the QIAGEN PCR Puriﬁcation Kit and
sequenced by standard chain-terminator methods. Sets of primers,
located less than 500 bp from each other and covering the whole 117–
4928 bp PCR product (see above) was employed to permit the
sequencing of the entire ampliﬁed region. To avoid mistakes, at least
two PCR products from separate reactions were sequenced for all viral
samples. The sequence of MVMp infectious clone pMM984 (Mer-
chlinsky et al., 1983) was determined between 117 and 4928 bp of the
MVMp genome. This sequence was aligned with DNA sequencing
results of the samples of interest, using the NCBI BLAST online
software. NCBI BLASTX was used to determine amino acid changes
caused by identiﬁed DNA mutations.
Structural analysis of mutated residues
The coordinates for the MVMp VP2 crystal structure (Kontou et al.,
2005) (PDB accession number 1z14) was used to map the positions of
the mutated residues onto the MVMp capsid. The icosahedral two-,
three- and ﬁve-fold related monomers were generated by applying
icosahedral symmetry operators to a reference monomer using the
program O (Jones et al., 1991) on a Silicon graphics Octane work-
station. The positions of the mutated residues were visualized and
analyzed in the context of the viral capsid using the program COOT(Emsley and Cowtan, 2004), and graphically presented using the
program PyMOL (DeLano, 2002).
CAT transfection assays
CAT reporter sequence under the control of WT and mutant P38
promoters were constructed as follows. pP38[WT]-CAT was con-
structed by sub-cloning the Eco RV/Hpa II restriction endonuclease
fragment (nt 383–5042 of MVMp) taken from pMM984 (Mer-
chlinsky et al., 1983), into the pGEM plasmid (Promega) EcoRV site.
Within this subclone the sequence between nt 2650 and 4212 was
released by cleavage with Hind III and BglII, and the CAT coding
sequence, released from pTS1 (Tratschin et al., 1986) with the same
enzymes, was substituted in its place. Mutant pP38[1955]-CAT was
made by substituting the WT MVM sequence between BstEII
(1884 bp) and XhoI (2070 bp) in pP38[WT]-CAT with sequence
derived from PCR-ampliﬁed F1 virus DNA. pNS was constructed by
releasing the NS coding region from pMM984 (Merchlinsky et al.,
1983) by cleavage with BamHI and Hind and cloning into the pGEM
EcoRV site.
All transfection experiments were performed in triplicate. 105
cells, seeded 12 h previously, in 6 well plates were co-transfected
with one of the CAT reporter constructs (pP38[WT]-CAT or pP38
[1955]-CAT) (500 ng/well), pNS (250 ng/well), and pSV2βgal
(Promega) (250 ng/well) as an internal control. 48 hpt cells were
harvested and 100 μl extract volumes were assayed for CAT and β-
gal activities (Gorman et al., 1982; Settleman and DiMaio, 1988). The
level of chloramphenicol acetylation was determined by overnight
exposure of thin-layer chromatography plates to a phosphor-imager
screen (FUJIFILM FLA-5100). Signal strengths of acetylated and non-
acetylated chloramphenicol forms were quantiﬁed with Image
Gauge software. The transfection efﬁciency was calculated from
the speciﬁc activity of β-galactosidase present in each extract.
Cell survival assay
MTT assays were performed in 96 well plates according to the
original protocol (Pauwels et al., 1988). OD values were adjusted to the
conﬂuence of living cells of all types.
Southern analysis
1 or 20 hpi cells werewashedwith PBS and lowmolecular DNAwas
extracted by the Hirt method (McMaster et al., 1981). Viral DNA and
LambdaDNA-HindIII marker (NEB)were resolved by agarose gel (0.8%)
electrophoresis (5 V/cm), capillary transferred (Sambrook and Russel,
2001) to a NytranN nylonmembrane (Schleicher & Schuell BioScience)
and hybridized according to the manufacturer's protocol to a mixed
probe of MVMp full-length genome and Lambda DNA, labeled by
254 I. Etingov et al. / Virology 379 (2008) 245–255random priming with 32P. After hybridization, membranes were
exposed to phosphor-imager screens (5 h) with subsequent develop-
ment by the phosphor-imager (FUJIFILM FLA-5100).
Northern analysis
mRNA of infected cells was extracted by the mRNA Direct Kit
(Chemagen) 14 hpi and quantiﬁed spectrophotometrically. Equal
amounts of mRNA from each sample were resolved with prolonged
(8 h) electrophoresis (2 V/cm) in 1% agarose gels, containing 2.2 M
formaldehyde following a standard protocol (Sambrook and Russel,
2001). RNA was then capillarily transferred to NytranN nylon
membranes (Schleicher & Schuell BioScience) and hybridized accord-
ing to the manufacturer's protocol to an MVMp genomic DNA probe
labeled by random priming with 32P. Images were developed by the
phosphor-imager as described for the Southern.
Western analysis
24 hpi total protein extraction was performed with RIPA buffer
(Bio-Rad) and quantiﬁed by a modiﬁed Bradford assay (Bio-Rad
Protein Assay Dye). Equal amounts of proteins from different samples
were resolved by discontinuous SDS-Polyacrylamide gel (8% for VP,
10% for NS proteins) electrophoresis and electrophoretically trans-
ferred to nitrocellulose membranes (Amersham Biotech), using a Bio-
Rad Mini-PROTEAN device, according to the manufacturer's protocols.
Immunoassaying was performed according to the standard protocol
(Sambrook and Russel, 2001), using rabbit-raised polyclonal pri-
mary antibodies for VP and NS proteins, kindly provided by Jean
Rommelaere (German Cancer Research Center) and Peroxidase-
labeled anti-rabbit secondary Ab (Amersham Biotech). ECL was
performed with Western Blotting Luminol Reagent (Santa Cruz) and
membranes were exposed to Kodak ML ﬁlms for 1 min.
In vivo infections
Neonate mice less than 16 h old were inoculated oral-nasally
with 103 PFU/mouse of virus in 4 μl of saline. 12 dpc mouse
embryos were inoculated by injection of 105 PFU/embryo of virus
into the embryonic liver in utero as described previously (Itah et
al., 2004a). After a further 48 hour incubation, both newborns and
embryos were dissected, embedded in Optimal Cutting Tempera-
ture (OCT), cryosectioned, and the sections were mounted on
slides. MVM capsid protein distribution in the tissues was
determined by immunohistochemistry using polyclonal anti-MVM
capsid antisera as described previously (Itah et al., 2004b).Acknowledgments
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